MD4341C1 - Syrup for the treatment of gastric precancerous conditions - Google Patents

Syrup for the treatment of gastric precancerous conditions

Info

Publication number
MD4341C1
MD4341C1 MDA20130088A MD20130088A MD4341C1 MD 4341 C1 MD4341 C1 MD 4341C1 MD A20130088 A MDA20130088 A MD A20130088A MD 20130088 A MD20130088 A MD 20130088A MD 4341 C1 MD4341 C1 MD 4341C1
Authority
MD
Moldova
Prior art keywords
vitamin
syrup
treatment
precancerous conditions
gastric precancerous
Prior art date
Application number
MDA20130088A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD4341B1 (en
Inventor
Ион МЕРЕУЦЭ
Владимир ВАЛИКА
Владимир КАРАУШ
Серджиу ПАРИЙ
Original Assignee
Ион МЕРЕУЦЭ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ион МЕРЕУЦЭ filed Critical Ион МЕРЕУЦЭ
Priority to MDA20130088A priority Critical patent/MD4341C1/en
Publication of MD4341B1 publication Critical patent/MD4341B1/en
Publication of MD4341C1 publication Critical patent/MD4341C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to gastroenterology, in particular to biologically active substances in the form of syrups, which can be used for the treatment of gastric precancerous conditions.According to the invention, the claimed syrup comprises: vitamin A, vitamin D2, vitamin E, vitamin C, vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12, biotin, folic acid, pantothenic acid, magnesium oxide, copper oxide, sodium selenate, nanoparticles of zinc oxide and silver, taken in the ratio of 9:1, and sugar syrup, in the following quantitative ratio of components per 100 ml:
MDA20130088A 2013-11-21 2013-11-21 Syrup for the treatment of gastric precancerous conditions MD4341C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20130088A MD4341C1 (en) 2013-11-21 2013-11-21 Syrup for the treatment of gastric precancerous conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20130088A MD4341C1 (en) 2013-11-21 2013-11-21 Syrup for the treatment of gastric precancerous conditions

Publications (2)

Publication Number Publication Date
MD4341B1 MD4341B1 (en) 2015-04-30
MD4341C1 true MD4341C1 (en) 2015-11-30

Family

ID=53002924

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20130088A MD4341C1 (en) 2013-11-21 2013-11-21 Syrup for the treatment of gastric precancerous conditions

Country Status (1)

Country Link
MD (1) MD4341C1 (en)

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002535A1 (en) * 1989-08-11 1991-03-07 Basil, Inc. Cancer prevention composition and method
DE4032187C2 (en) * 1990-10-10 1995-03-30 Gradinger F Hermes Pharma N-Retinoyl-L-aminomercapto compounds and intermediates, process for their preparation and their use
DE4032163C2 (en) * 1990-10-10 1995-03-30 Gradinger F Hermes Pharma S-retinoyl-L-aminomercapto compounds and intermediates, processes for their preparation and their use
RU2034560C1 (en) * 1993-05-18 1995-05-10 Товарищество с ограниченной ответственностью "Фитолон" Cancer prevention "clamin" remedy
CN1093402C (en) * 1998-08-11 2002-10-30 苏乐群 Gastritis treating tablet
RU2205656C1 (en) * 2002-06-27 2003-06-10 Общество с ограниченной ответственностью Фирма "ЭЙКОСЪ" Biologically active supplement "antiyazvennye" for prophylaxis and supporting therapy in digestive tract diseases
NZ529115A (en) * 2001-04-20 2005-08-26 Boehringer Ingelheim Pharma Use of probucol, ascorbic acid, vitamin E, dipyridamole and mopidamol for treatment and prevention of NO-dependent microcirculation disorders
CN1698646A (en) * 2005-04-29 2005-11-23 朱舜时 Medicine composition for treating atrophic gastritis
CN1927311A (en) * 2006-09-19 2007-03-14 陈楚挺 Drug for treating chronic atrophic gastritis precancerous lesion and finished capsule product thereof
MD3972C2 (en) * 2009-03-11 2010-07-31 Ион МЕРЕУЦЭ Remedy and method for treating precancerous conditions
RU2473357C2 (en) * 2011-02-24 2013-01-27 Общество с ограниченной ответственностью "ДИНАМИК ДЕВЕЛОПМЕНТ ЛАБОРАТОРИЗ" Liquid composition improving working performance and possessing adaptogenic, wound-healing and anti-inflammatory action
CN103230431A (en) * 2013-04-27 2013-08-07 洪士炀 Medicine for treating stomach disease and application
CN103082299B (en) * 2012-12-26 2014-07-30 东莞市照燕生物科技有限公司 Nutritional healthcare product for clearing bowels and expelling toxin

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002535A1 (en) * 1989-08-11 1991-03-07 Basil, Inc. Cancer prevention composition and method
DE4032187C2 (en) * 1990-10-10 1995-03-30 Gradinger F Hermes Pharma N-Retinoyl-L-aminomercapto compounds and intermediates, process for their preparation and their use
DE4032163C2 (en) * 1990-10-10 1995-03-30 Gradinger F Hermes Pharma S-retinoyl-L-aminomercapto compounds and intermediates, processes for their preparation and their use
RU2034560C1 (en) * 1993-05-18 1995-05-10 Товарищество с ограниченной ответственностью "Фитолон" Cancer prevention "clamin" remedy
CN1093402C (en) * 1998-08-11 2002-10-30 苏乐群 Gastritis treating tablet
NZ529115A (en) * 2001-04-20 2005-08-26 Boehringer Ingelheim Pharma Use of probucol, ascorbic acid, vitamin E, dipyridamole and mopidamol for treatment and prevention of NO-dependent microcirculation disorders
RU2205656C1 (en) * 2002-06-27 2003-06-10 Общество с ограниченной ответственностью Фирма "ЭЙКОСЪ" Biologically active supplement "antiyazvennye" for prophylaxis and supporting therapy in digestive tract diseases
CN1698646A (en) * 2005-04-29 2005-11-23 朱舜时 Medicine composition for treating atrophic gastritis
CN1927311A (en) * 2006-09-19 2007-03-14 陈楚挺 Drug for treating chronic atrophic gastritis precancerous lesion and finished capsule product thereof
MD3972C2 (en) * 2009-03-11 2010-07-31 Ион МЕРЕУЦЭ Remedy and method for treating precancerous conditions
RU2473357C2 (en) * 2011-02-24 2013-01-27 Общество с ограниченной ответственностью "ДИНАМИК ДЕВЕЛОПМЕНТ ЛАБОРАТОРИЗ" Liquid composition improving working performance and possessing adaptogenic, wound-healing and anti-inflammatory action
CN103082299B (en) * 2012-12-26 2014-07-30 东莞市照燕生物科技有限公司 Nutritional healthcare product for clearing bowels and expelling toxin
CN103230431A (en) * 2013-04-27 2013-08-07 洪士炀 Medicine for treating stomach disease and application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Регистр лекарственных средств. Энциклопедия лекарств. Выпуск 21, 2012, p. 1426 *

Also Published As

Publication number Publication date
MD4341B1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
AR081551A1 (en) COMPOSITIONS AND DRINKS THAT INCLUDE NUTRIENTS, VITAMINS, SUGARS, CYSTEINE AND / OR SUGAR-CYSTEINE PRODUCTS
NZ732700A (en) Microencapsulated cannabinoid compositions
MX2016002765A (en) Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid.
CL2009002198A1 (en) Dietary supplement in the form of a soft gel comprising lutein, zeaxanthin, vitamins c, e, d, b1, b2, b3, b6 and b12, copper, zinc, folate / folic acid, selenium, manganese, epa, dha and water, which is ingested once a day to provide the daily dosage amount; and methods to reduce the ocular inflammatory response.
WO2015034812A3 (en) A new ketogenic diet and its use in treating the critically ill
BR112012017868A2 (en) "gel-based composition and manufacturing methods"
GB201316021D0 (en) Vitamin D composition
MX2018003975A (en) Combination of glycosaminoglycans and an antacid agent and compositions thereof.
AR098653A1 (en) USEFUL COMPOSITION TO PROMOTE FEMALE FERTILITY, COMBINATION COMPOSITION
MX2011012297A (en) The improvement of gastrointestinal health, immunity and performance by dietary intervention.
MX2013004371A (en) Cysteine and food intake.
AR100028A1 (en) NUTRITIONAL COMPOSITIONS CONTAINING ESTEARIDÓNIC ACID
MD4341B1 (en) Syrup for the treatment of gastric precancerous conditions
GB201207939D0 (en) Nutraceutical composition that comprises extract of shilajit, folic acid, vitamin b12 and vitamin b6 and the use thereof for preventing and/or treating neurod
MX360934B (en) Trace element solution.
PH12015502019A1 (en) Sequestrants of advanced glycation end product (age) precursors
MX2015011540A (en) Oral electrolyte solution containing lactoferrin and uses thereof.
MX2018013148A (en) Nutritional supplements.
MX364920B (en) Process for obtaining a flour reduced in astringency, with a high content of fiber, vitamin a and vitamin c from the cashew pseudocarp (anacardium occidentale l.), uses and applications thereof.
UA86343U (en) Composition of marmalade "svizhist" (freshness) with envigorating properties
UA90307U (en) Method for treating food intoxication with apple vinegar
Khandheria Acute psychosis: case report
UA106282C2 (en) Juice soft drink "zolota troianda" (golden rose)
UA92875U (en) Method of cardiovascular diseases prevention
UA75625U (en) Brittle

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees